Experience today’s and tomorrow’s
metal-based APIs
Committed to hassle-free co-operations, Umicore
develops and manufactures first-class metal-based
APIs, which enables its partners to concentrate
on marketing the drugs.
Umicore is globally recognised with more than 40 years of leadership in precious metals chemistry and over a decade of platinum active pharmaceutical ingredients (API) experience.
After obtaining 60% platinum API market share in Latin America, the company invested $8 million in the construction of a state-of-the-art greenfield API plant in Argentina. Opened in January 2009, the plant now flexibly supplies platinum APIs to key oncology players globally. The new plant has also increased the company’s production capacity, and is able to cover 50% of the worldwide demand for platinum API products.
International standards
Making optimum use of its unique metallurgy and chemistry expertise, Umicore today produces the most important oncology platinum APIs: cisplatin, carboplatin and oxaliplatin Following ‘The Umicore Way’, APIs are manufactured according to the highest quality and social standards. The GMP-approved plant produces under the USP, EP and JP guidelines and is compliant with ISO 9001 and 14001. Needless to say, the plant and the product documentation comply with the most stringent
international standards.
As the platinum API production is fully integrated into Umicore’s closed metal loop concept, customers are assured of continuous platinum availability, due to Umicore’s recycling operations. Customers can also count on the active support of the company’s dedicated marketing and sales teams located in more than 50 locations worldwide.
Product partners
Alongside platinum APIs, Umicore’s research and development team has started developing other metal-based APIs to be produced in the new plant. The preferred business model is a cooperation where Umicore develops and manufactures the API and its partner concentrates on developing and marketing the drug. Umicore is actively looking for new partners interested in developing new products.
Umicore is a leading manufacturer of highly pure and active precious metals
catalysts and chemicals for use in a broad array
of industries, spanning from automotive catalyst
manufacturing to the pharmaceutical industry.
Besides its expertise in metal-based APIs, Umicore
has developed a wide range of organometallic precious
metal catalysts and precursors, which are used
primarily for homogeneous catalysis applications
and have been enabling the implementation of innovative
and cost-effective commercial scale processes
in the life science industries.
|
 |
Company profile
Umicore
For further information, visit: www.chemistry.umicore.com
email: api@umicore.com
|
